Novavax | NVAX - Lucro Bruto Sobre Vendas





Lucro Bruto Sobre Vendas Alterar Data
Adma Biologics USD 80.75M 8.07M 2026-03
Agenus USD 33.74M 468K 2026-03
AstraZeneca USD 12.86B 251M 2026-06
BioCryst Pharmaceuticals USD 214.41M 61.36M 2026-06
Cassava Sciences USD -3.96M 1.16M 2025-09
Geron USD 50.14M 3.44M 2026-03
GlaxoSmithKline GBP 6.51B 757M 2026-06
MannKind USD 7.77M 60.56M 2026-06
Merck USD 12.09B 1.24B 2026-03
Minerva Neurosciences -4.27M 26.79M 2024-12
Moderna USD -566M 792M 2026-03
Novartis USD 10.07B 758M 2026-03
Novavax USD 125.04M 76.09M 2025-12
Pfizer USD -248M 11.29B 2026-06
Sanofi EUR 8.71B 602M 2026-06
Sarepta Therapeutics USD 251.15M 370.2M 2026-06
TG Therapeutics USD 199.14M 27.73M 2026-06